These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 18613319)

  • 1. A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling.
    Wakefield CE; Meiser B; Homewood J; Taylor A; Gleeson M; Williams R; Tucker K;
    Psychooncology; 2008 Aug; 17(8):844-54. PubMed ID: 18613319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk.
    Wakefield CE; Meiser B; Homewood J; Peate M; Taylor A; Lobb E; Kirk J; Young MA; Williams R; Dudding T; Tucker K;
    Breast Cancer Res Treat; 2008 Jan; 107(2):289-301. PubMed ID: 17333332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of a decision aid for individuals considering genetic testing for hereditary nonpolyposis colorectal cancer risk.
    Wakefield CE; Meiser B; Homewood J; Ward R; O'Donnell S; Kirk J;
    Cancer; 2008 Sep; 113(5):956-65. PubMed ID: 18618513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation.
    Metcalfe KA; Poll A; O'Connor A; Gershman S; Armel S; Finch A; Demsky R; Rosen B; Narod SA
    Clin Genet; 2007 Sep; 72(3):208-17. PubMed ID: 17718858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of an information booklet on satisfaction and decision-making about BRCA genetic testing.
    Mancini J; Noguès C; Adenis C; Berthet P; Bonadona V; Chompret A; Coupier I; Eisinger F; Fricker JP; Gauthier-Villars M; Lasset C; Lortholary A; N'Guyen TD; Vennin P; Sobol H; Stoppa-Lyonnet D; Julian-Reynier C
    Eur J Cancer; 2006 May; 42(7):871-81. PubMed ID: 16563745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receiving inconclusive genetic test results: an interpretive description of the BRCA1/2 experience.
    Maheu C; Thorne S
    Res Nurs Health; 2008 Dec; 31(6):553-62. PubMed ID: 18449940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making.
    Matloff ET; Moyer A; Shannon KM; Niendorf KB; Col NF
    J Womens Health (Larchmt); 2006 Sep; 15(7):843-56. PubMed ID: 16999640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial of a decision aid for women at increased risk of ovarian cancer.
    Tiller K; Meiser B; Gaff C; Kirk J; Dudding T; Phillips KA; Friedlander M; Tucker K
    Med Decis Making; 2006; 26(4):360-72. PubMed ID: 16855125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers.
    van Roosmalen MS; Stalmeier PF; Verhoef LC; Hoekstra-Weebers JE; Oosterwijk JC; Hoogerbrugge N; Moog U; van Daal WA
    J Clin Oncol; 2004 Aug; 22(16):3293-301. PubMed ID: 15310772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients' resistance to risk information in genetic counseling for BRCA1/2.
    Gurmankin AD; Domchek S; Stopfer J; Fels C; Armstrong K
    Arch Intern Med; 2005 Mar; 165(5):523-9. PubMed ID: 15767527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort.
    Fortuny D; Balmaña J; Graña B; Torres A; Ramón y Cajal T; Darder E; Gadea N; Velasco A; López C; Sanz J; Alonso C; Brunet J
    Hum Reprod; 2009 Apr; 24(4):1000-6. PubMed ID: 19112076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced counseling for women undergoing BRCA1/2 testing: impact on subsequent decision making about risk reduction behaviors.
    Miller SM; Roussi P; Daly MB; Buzaglo JS; Sherman K; Godwin AK; Balshem A; Atchison ME
    Health Educ Behav; 2005 Oct; 32(5):654-67. PubMed ID: 16148211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychological distress and quality of life associated with genetic testing for breast cancer risk.
    Smith AW; Dougall AL; Posluszny DM; Somers TJ; Rubinstein WS; Baum A
    Psychooncology; 2008 Aug; 17(8):767-73. PubMed ID: 17992698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recall of and reactions to a surgeon referral letter for BRCA genetic counseling among high-risk breast cancer patients.
    Vadaparampil ST; Quinn GP; Miree CA; Brzosowicz J; Carter B; Laronga C
    Ann Surg Oncol; 2009 Jul; 16(7):1973-81. PubMed ID: 19408048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subjective and objective risk of ovarian cancer in Ashkenazi Jewish women testing for BRCA1/2 mutations.
    Kelly KM; Senter L; Leventhal H; Ozakinci G; Porter K
    Patient Educ Couns; 2008 Jan; 70(1):135-42. PubMed ID: 17988821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
    Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
    JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized comparison of group versus individual genetic education and counseling for familial breast and/or ovarian cancer.
    Calzone KA; Prindiville SA; Jourkiv O; Jenkins J; DeCarvalho M; Wallerstedt DB; Liewehr DJ; Steinberg SM; Soballe PW; Lipkowitz S; Klein P; Kirsch IR
    J Clin Oncol; 2005 May; 23(15):3455-64. PubMed ID: 15908654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a decision aid for prenatal testing of fetal abnormalities to improve women's informed decision making: a cluster randomised controlled trial [ISRCTN22532458].
    Nagle C; Gunn J; Bell R; Lewis S; Meiser B; Metcalfe S; Ukoumunne OC; Halliday J
    BJOG; 2008 Feb; 115(3):339-47. PubMed ID: 18190370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One risk fits all?
    De Bock GH; Mourits MJ; Oosterwijk JC
    J Clin Oncol; 2007 Aug; 25(22):3383-4; author reply 3384. PubMed ID: 17664491
    [No Abstract]   [Full Text] [Related]  

  • 20. Development and pilot testing of a decision aid for men considering genetic testing for breast and/or ovarian cancer-related mutations (BRCA1/2).
    Juan AS; Wakefield CE; Kasparian NA; Kirk J; Tyler J; Tucker K
    Genet Test; 2008 Dec; 12(4):523-32. PubMed ID: 19072564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.